98P Efficacy and safety of durvalumab plus gemcitabine and cisplatin in Chinese participants with advanced biliary tract cancer: Extension cohort of the phase III, randomised, double-blind, placebo-controlled, global TOPAZ-1 study

S. Qin,J-Q. Cai, E. Li, B. Xing, L. Zhao, C. Dai, J. Li, Y. Shen, Z. Chen,L. Liu,Z. Lu, A. Zang, Y. Bai,H. Liang, J. Liang,X. Liu, J. Wang,M-H. Chen,R. Miao, X. Qu

Annals of Oncology（2023）

Cited 0|Views23

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined